Edition:
United States

Integragen SA (ALINT.PA)

ALINT.PA on Paris Stock Exchange

2.81EUR
24 Mar 2017
Change (% chg)

€0.03 (+1.08%)
Prev Close
€2.78
Open
€2.78
Day's High
€2.88
Day's Low
€2.75
Volume
14,907
Avg. Vol
33,696
52-wk High
€4.29
52-wk Low
€2.55

Latest Key Developments (Source: Significant Developments)

Integragen and Laboratoire Cerba agree to commercialize tumor expression test
Wednesday, 8 Mar 2017 02:28am EST 

Integragen SA : Integragen and Laboratoire Cerba sign licensing agreement to commercialize miR-31-3p tumor expression test . Signing of a licensing agreement allowing Laboratoire Cerba to develop and provide a test based on Integragen's proprietary miR-31-3p biomarker .CEO of Laboratoire Cerba looks forward to making this test available for clinicians in the first half of 2017 once we have completed the validation steps in our laboratory.  Full Article

Integragen successfully completes 3.7 mln euro capital increase
Friday, 3 Feb 2017 01:35am EST 

Integragen SA : Successfully completes a 3.7 million euro ($4.0 million)capital increase reserved for one class of investors . Aims to speed up its development by supporting the deployment of its new activities .To issue 1,466,622 shares with a nominal value of 1 euro, at a unit price of 2.53 euros, representing a discount of 17 percent on Feb 2 closing price.  Full Article

Integragen reports sharp increase in sales during 2016
Monday, 9 Jan 2017 12:07pm EST 

Integragen SA : Fy revenue 6.0 million euros ($6.34 million) versus 5.6 million euros year ago .Growth in orders in 2016 was higher than revenues, making it possible to anticipate sustained activity in 2017.  Full Article

Integragen H1 net loss widens to 1.0 million euros
Friday, 14 Oct 2016 01:45am EDT 

Integragen SA :H1 net loss 1.0 million euros versus loss of 0.9 million euros year ago.  Full Article

Integragen H1 revenue 2.8 million euros, up more than 10 pct
Thursday, 7 Jul 2016 01:30am EDT 

Integragen SA : H1 revenue of 2.8 million euros ($3.11 million), up more than 10 pct compared to first half 2015 .H1 new orders recorded a 9 pct increase compared to same time period in 2015.  Full Article

AP-HP and IntegraGen agree to research partnership
Thursday, 30 Jun 2016 02:29am EDT 

Integragen SA :Announced on Wednesday that Greater Paris University Hospitals, AP-HP and IntegraGen agree to a research partnership to develop a common platform for high-throughput sequencing.  Full Article

IntegraGen collaborates with FIRE-3 clinical trial investigators
Wednesday, 2 Dec 2015 12:00pm EST 

IntegraGen SA:Integragen collaborating with FIRE-3 clinical trial investigators to study HSA-MIR-31-3P metastatic colorectal cancer biomarker.  Full Article

Gustave Roussy and IntegraGen announce completion of over 1000 tests in less than 18 months
Tuesday, 17 Nov 2015 02:45am EST 

IntegraGen SA:Gustave Roussy and IntegraGen announce completion of more than a thousand tests in less than eighteen months.  Full Article

Integragen SA results identify new virus implicated in development of liver cancer
Tuesday, 25 Aug 2015 12:00pm EDT 

Integragen SA:Results of sequencing of 193 hepatic tumors produced by Integragen identify a new virus implicated in the development of liver cancer.  Full Article

IntegraGen announces cooperation agreement with the Hopital Europeen Georges Pompidou
Wednesday, 8 Jul 2015 02:00am EDT 

IntegraGen SA:Announces cooperation agreement with the Hopital Europeen Georges Pompidou for access to a high-volume sequencing platform.  Full Article

More From Around the Web